Haystack Oncology logo
Healthcare & Life Sciences

Haystack Oncology

Haystack Oncology is a Healthcare & Life Sciences startup based in the United States, most recent round Series A, 1 tracked investor.

Activeseries-a
series-a
Stage
2021
Founded
1
Investors

About Haystack Oncology

Based in the United States, Haystack Oncology is a startup founded in 2021. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

Haystack Oncology develops and provides a tumor-informed minimal residual disease (MRD) test called Haystack MRD that detects circulating tumor DNA in blood to assist clinicians and biopharma in detecting residual or recurring solid tumor cancers with high accuracy.

Explore Haystack Oncology's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

Other Startups in United States